Trademark: 97244486
Status Date
Thursday, December 21, 2023
Filing Date
Friday, January 28, 2022
Published for Opposition
Tuesday, November 8, 2022
5 Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva; Vaccines
Dec 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2023
Sou Extension 2 Granted
Dec 21, 2023
Sou Extension 2 Filed
Dec 21, 2023
Sou Teas Extension Received
Jun 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2023
Sou Extension 1 Granted
Jun 26, 2023
Sou Extension 1 Filed
Jun 26, 2023
Sou Teas Extension Received
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 4, 2022
Approved For Pub - Principal Register
Sep 8, 2022
Teas/Email Correspondence Entered
Sep 7, 2022
Correspondence Received In Law Office
Sep 7, 2022
Teas Response To Office Action Received
Mar 14, 2022
Notification Of Non-Final Action E-Mailed
Mar 14, 2022
Non-Final Action E-Mailed
Mar 14, 2022
Non-Final Action Written
Mar 14, 2022
Notification Of Non-Final Action E-Mailed
Mar 14, 2022
Non-Final Action E-Mailed
Mar 14, 2022
Non-Final Action Written
Mar 7, 2022
Assigned To Examiner
Feb 7, 2022
Teas Amendment Entered Before Attorney Assigned
Feb 7, 2022
Teas Voluntary Amendment Received
Feb 1, 2022
New Application Office Supplied Data Entered
Feb 1, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
